Literature DB >> 2547870

Epstein-Barr virus preferentially induces proliferation of primed B cells.

M J Crain1, S K Sanders, J L Butler, M D Cooper.   

Abstract

EBV can induce human B cells to proliferate, differentiate, and undergo transformation into continuously growing lymphoblastoid cell lines. The EBV responsiveness appears to be confined to a very limited subpopulation of B cells, the nature of which is still unclear. In these studies, we sorted tonsillar B cells on the basis of their expression of the early surface activation Ag, Bac-1, and compared their proliferative responses to EBV. Bac-1+ cells responded to EBV with a relatively high level of DNA synthesis, whereas the Bac-1- cells did not. Both large and small Bac-1+ cells were responsive to EBV and the responsiveness was unrelated to the level of Bac-1 immunofluorescence intensity. Bac-1+ cells were relatively enriched for surface IgM and IgD expression. When the Bac-1- population was enriched for IgM+ cells, the proliferative response was still significantly lower than that of the Bac-1+ population. B cells acquire the ability to bind IgM relatively late after activation, and this feature did not distinguish the EBV-responsive B cells. The results suggest B cells become responsive to EBV after an early activation signal.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547870

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Generation of stable human autoantibody-secreting B cell hybridomas.

Authors:  N Chiorazzi
Journal:  Mol Biol Rep       Date:  1992-05       Impact factor: 2.316

2.  Epitope analysis of peanut allergen Ara h1 with human monoclonal IgM antibody 92-2.

Authors:  Hiroshi Shinmoto; Yuji Matsuo; Yasunori Naganawa; Shinichi Tomita; Yuko Takano-Ishikawa
Journal:  Cytotechnology       Date:  2009-12-19       Impact factor: 2.058

3.  Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes.

Authors:  C Huang; A K Stewart; R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Authors:  Thomas Tiller; Eric Meffre; Sergey Yurasov; Makoto Tsuiji; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Immunol Methods       Date:  2007-10-31       Impact factor: 2.303

Review 5.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

6.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus.

Authors:  Jiansheng Lu; Rong Wang; Binghui Xia; Yunzhou Yu; Xiaowei Zhou; Zhixin Yang; Peitang Huang
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

8.  Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

Authors:  Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Jörn E Schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Journal:  PLoS Med       Date:  2009-07-07       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.